WHERE
NEUROSCIENCE LEADERS CONNECT
Broadreach Global is a focused boutique advisory firm that has built — over two decades — the most consequential network in global neuroscience innovation.
We work at the intersection of drug development, gene therapy, platform technologies and neurotech, with the founders, CEOs and decision-makers who are shaping the future of brain health.
THE NETWORK
25+
Years at the heart of biotech and neuroscience innovation
200+
Biotech CEOs, investors & pharma decision-makers in our annual summit
5
Continents. One singular core focus: neuroscience.
selective
We engage with a small number of priority partners each year
AT THE CONVERGENCE
OF THE NEUROSCIENCE WORLD
At Broadreach Global, our work and our convening bring together — by invitation and by relationship — the full spectrum of leadership that drives neuroscience forward:
Founders and CEOs of leading private and public biotech companies in CNS drug development, gene therapies, advanced platforms and neurotech – in dedicated, specialized convenings.
Heads of neuroscience therapeutic areas, R&D, business development, scouting, licensing and alliances at the world's leading pharma and large biotech
Managing Partners and Partners of the most active neuroscience-focused venture capital, corporate venture and specialist investment funds globally
Pioneering scientists, clinicians and KOLs whose work is translating discovery into therapy
Senior executives
from leading investment banks advising on M&A, licensing and capital raises in the neuroscience space
These relationships — built over more than two decades in the biotech and neuroscience sectors — are not acquired. They are built, and continuously earned.
THAT IS THE BROADREACH DIFFERENCE.
NEUROSCIENCE EVENTS
OUR EVENT ECOSYSTEMS
The key partnering and investment summit for global leaders in CNS neuroscience drug discovery and development.
Bio-Neuroscience convenes an outstanding mix of innovators, CEOs and decision-makers in CNS neuroscience drug development from the leading biotech companies, investors and pharma companies in the sector.
TESTIMONIALS
An intimate and engaging meeting, providing an opportunity for business leaders in neuroscience to explore collective challenges and opportunities in this rapidly evolving field.
Aaron Koenig
CMO, Delix Therapeutics
